Top 5 Stocks to Buy Now
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free XRN Stock Alerts

Global Medical REIT (XRN) Competitors

Global Medical REIT logo
$36.31 +0.54 (+1.51%)
Closing price 06/24/2026 03:59 PM Eastern
Extended Trading
$36.33 +0.02 (+0.05%)
As of 06/24/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

XRN vs. SILA, PBT, ORC, LADR, and APPS

Should you buy Global Medical REIT stock or one of its competitors? MarketBeat compares Global Medical REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Global Medical REIT include Sila Realty Trust (SILA), Permian Basin Royalty Trust (PBT), Orchid Island Capital (ORC), Ladder Capital (LADR), and Digital Turbine (APPS). These companies are all part of the "trading" industry.

How does Global Medical REIT compare to Sila Realty Trust?

Sila Realty Trust (NYSE:SILA) and Global Medical REIT (NYSE:XRN) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

Sila Realty Trust has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Global Medical REIT has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

57.5% of Global Medical REIT shares are owned by institutional investors. 0.8% of Sila Realty Trust shares are owned by insiders. Comparatively, 8.9% of Global Medical REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Sila Realty Trust has a net margin of 18.64% compared to Global Medical REIT's net margin of -6.06%. Sila Realty Trust's return on equity of 2.81% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sila Realty Trust18.64% 2.81% 1.81%
Global Medical REIT -6.06%-2.19%-0.73%

Sila Realty Trust has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Sila Realty Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sila Realty Trust$197.54M8.48$33.12M$0.6745.28
Global Medical REIT$148.21M3.24-$5.84M-$1.11N/A

In the previous week, Sila Realty Trust's average media sentiment score of 1.80 beat Global Medical REIT's score of 1.00 indicating that Sila Realty Trust is being referred to more favorably in the media.

Company Overall Sentiment
Sila Realty Trust Very Positive
Global Medical REIT Positive

Sila Realty Trust pays an annual dividend of $1.60 per share and has a dividend yield of 5.3%. Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.3%. Sila Realty Trust pays out 238.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Global Medical REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Sila Realty Trust currently has a consensus target price of $29.00, indicating a potential downside of 4.40%. Global Medical REIT has a consensus target price of $40.00, indicating a potential upside of 10.16%. Given Global Medical REIT's stronger consensus rating and higher probable upside, analysts plainly believe Global Medical REIT is more favorable than Sila Realty Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sila Realty Trust
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38

Summary

Sila Realty Trust and Global Medical REIT tied by winning 9 of the 18 factors compared between the two stocks.

How does Global Medical REIT compare to Permian Basin Royalty Trust?

Global Medical REIT (NYSE:XRN) and Permian Basin Royalty Trust (NYSE:PBT) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Global Medical REIT has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Permian Basin Royalty Trust has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market.

Permian Basin Royalty Trust has a net margin of 88.99% compared to Global Medical REIT's net margin of -6.06%. Permian Basin Royalty Trust's return on equity of 9,061.81% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Permian Basin Royalty Trust 88.99%9,061.81%484.53%

Permian Basin Royalty Trust has lower revenue, but higher earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Permian Basin Royalty Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.24-$5.84M-$1.11N/A
Permian Basin Royalty Trust$16.13M71.33$14.30M$0.3277.14

Global Medical REIT presently has a consensus price target of $40.00, indicating a potential upside of 10.16%. Given Global Medical REIT's stronger consensus rating and higher probable upside, equities research analysts clearly believe Global Medical REIT is more favorable than Permian Basin Royalty Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Permian Basin Royalty Trust
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

57.5% of Global Medical REIT shares are held by institutional investors. Comparatively, 28.9% of Permian Basin Royalty Trust shares are held by institutional investors. 8.9% of Global Medical REIT shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.3%. Permian Basin Royalty Trust pays an annual dividend of $0.24 per share and has a dividend yield of 1.0%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Permian Basin Royalty Trust pays out 75.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Global Medical REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Permian Basin Royalty Trust had 4 more articles in the media than Global Medical REIT. MarketBeat recorded 4 mentions for Permian Basin Royalty Trust and 0 mentions for Global Medical REIT. Permian Basin Royalty Trust's average media sentiment score of 1.04 beat Global Medical REIT's score of 1.00 indicating that Permian Basin Royalty Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Global Medical REIT Positive
Permian Basin Royalty Trust Positive

Summary

Global Medical REIT beats Permian Basin Royalty Trust on 10 of the 19 factors compared between the two stocks.

How does Global Medical REIT compare to Orchid Island Capital?

Global Medical REIT (NYSE:XRN) and Orchid Island Capital (NYSE:ORC) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Global Medical REIT has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Orchid Island Capital has a beta of 1.55, meaning that its stock price is 55% more volatile than the broader market.

Global Medical REIT currently has a consensus target price of $40.00, indicating a potential upside of 10.16%. Orchid Island Capital has a consensus target price of $7.50, indicating a potential upside of 10.21%. Given Orchid Island Capital's higher possible upside, analysts plainly believe Orchid Island Capital is more favorable than Global Medical REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Orchid Island Capital
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.3%. Orchid Island Capital pays an annual dividend of $1.20 per share and has a dividend yield of 17.6%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Orchid Island Capital pays out 160.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Orchid Island Capital has raised its dividend for 1 consecutive years. Orchid Island Capital is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Orchid Island Capital has a net margin of 0.00% compared to Global Medical REIT's net margin of -6.06%. Orchid Island Capital's return on equity of 10.24% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Orchid Island Capital N/A 10.24%1.19%

57.5% of Global Medical REIT shares are owned by institutional investors. Comparatively, 32.7% of Orchid Island Capital shares are owned by institutional investors. 8.9% of Global Medical REIT shares are owned by company insiders. Comparatively, 0.3% of Orchid Island Capital shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Orchid Island Capital had 4 more articles in the media than Global Medical REIT. MarketBeat recorded 4 mentions for Orchid Island Capital and 0 mentions for Global Medical REIT. Global Medical REIT's average media sentiment score of 1.00 beat Orchid Island Capital's score of 0.88 indicating that Global Medical REIT is being referred to more favorably in the media.

Company Overall Sentiment
Global Medical REIT Positive
Orchid Island Capital Positive

Orchid Island Capital has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Orchid Island Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.24-$5.84M-$1.11N/A
Orchid Island Capital$414M3.30$159.03M$0.759.07

Summary

Orchid Island Capital beats Global Medical REIT on 13 of the 20 factors compared between the two stocks.

How does Global Medical REIT compare to Ladder Capital?

Global Medical REIT (NYSE:XRN) and Ladder Capital (NYSE:LADR) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Global Medical REIT has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Ladder Capital has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market.

57.5% of Global Medical REIT shares are held by institutional investors. Comparatively, 62.3% of Ladder Capital shares are held by institutional investors. 8.9% of Global Medical REIT shares are held by company insiders. Comparatively, 12.0% of Ladder Capital shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.3%. Ladder Capital pays an annual dividend of $0.92 per share and has a dividend yield of 9.0%. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Ladder Capital pays out 209.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Ladder Capital has a net margin of 13.82% compared to Global Medical REIT's net margin of -6.06%. Ladder Capital's return on equity of 5.73% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Medical REIT-6.06% -2.19% -0.73%
Ladder Capital 13.82%5.73%1.70%

Ladder Capital has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Ladder Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Medical REIT$148.21M3.24-$5.84M-$1.11N/A
Ladder Capital$390.29M3.34$64.18M$0.4423.28

Global Medical REIT currently has a consensus price target of $40.00, suggesting a potential upside of 10.16%. Ladder Capital has a consensus price target of $12.75, suggesting a potential upside of 24.45%. Given Ladder Capital's stronger consensus rating and higher probable upside, analysts clearly believe Ladder Capital is more favorable than Global Medical REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38
Ladder Capital
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Global Medical REIT's average media sentiment score of 1.00 beat Ladder Capital's score of 0.00 indicating that Global Medical REIT is being referred to more favorably in the media.

Company Overall Sentiment
Global Medical REIT Positive
Ladder Capital Neutral

Summary

Ladder Capital beats Global Medical REIT on 14 of the 18 factors compared between the two stocks.

How does Global Medical REIT compare to Digital Turbine?

Digital Turbine (NASDAQ:APPS) and Global Medical REIT (NYSE:XRN) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Digital Turbine had 1 more articles in the media than Global Medical REIT. MarketBeat recorded 1 mentions for Digital Turbine and 0 mentions for Global Medical REIT. Digital Turbine's average media sentiment score of 1.39 beat Global Medical REIT's score of 1.00 indicating that Digital Turbine is being referred to more favorably in the media.

Company Overall Sentiment
Digital Turbine Positive
Global Medical REIT Positive

Digital Turbine has a beta of 2.85, meaning that its stock price is 185% more volatile than the broader market. Comparatively, Global Medical REIT has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

Digital Turbine presently has a consensus target price of $8.75, suggesting a potential downside of 13.71%. Global Medical REIT has a consensus target price of $40.00, suggesting a potential upside of 10.16%. Given Global Medical REIT's higher probable upside, analysts plainly believe Global Medical REIT is more favorable than Digital Turbine.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Turbine
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
Global Medical REIT
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.38

Global Medical REIT has lower revenue, but higher earnings than Digital Turbine. Global Medical REIT is trading at a lower price-to-earnings ratio than Digital Turbine, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Turbine$565.25M2.16-$37.73M-$0.36N/A
Global Medical REIT$148.21M3.24-$5.84M-$1.11N/A

63.7% of Digital Turbine shares are held by institutional investors. Comparatively, 57.5% of Global Medical REIT shares are held by institutional investors. 6.1% of Digital Turbine shares are held by company insiders. Comparatively, 8.9% of Global Medical REIT shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Global Medical REIT has a net margin of -6.06% compared to Digital Turbine's net margin of -6.68%. Digital Turbine's return on equity of 27.60% beat Global Medical REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Turbine-6.68% 27.60% 5.68%
Global Medical REIT -6.06%-2.19%-0.73%

Summary

Digital Turbine beats Global Medical REIT on 10 of the 15 factors compared between the two stocks.

Get Global Medical REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for XRN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XRN vs. The Competition

Export
MetricGlobal Medical REITREIT IndustryFinance SectorNYSE Exchange
Market Cap$473.41M$10.01B$13.95B$23.13B
Dividend Yield5.37%4.93%5.73%4.05%
P/E Ratio-32.7149.7220.2831.08
Price / Sales3.245.32139.5121.49
Price / Cash8.5914.4419.4824.30
Price / Book1.202.102.244.67
Net Income-$5.84M$227.95M$1.14B$1.07B
7 Day Performance3.69%2.79%0.53%0.24%
1 Month Performance-2.97%3.36%1.11%0.36%
1 Year Performance10.79%12.51%15.03%22.63%

Global Medical REIT Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XRN
Global Medical REIT
3.2928 of 5 stars		$36.31
+1.5%		$40.00
+10.2%		+10.8%$473.41M$148.21MN/A30
SILA
Sila Realty Trust
2.5539 of 5 stars		$30.30
+0.0%		$29.00
-4.3%		+25.6%$1.67B$197.54M45.2248
PBT
Permian Basin Royalty Trust
1.5377 of 5 stars		$27.19
-4.4%		N/A+103.5%$1.33B$16.13M84.97N/A
ORC
Orchid Island Capital
2.363 of 5 stars		$6.62
+1.5%		$7.50
+13.4%		-3.5%$1.31B$414M8.822,018
LADR
Ladder Capital
4.6589 of 5 stars		$10.09
-0.4%		$12.75
+26.4%		-4.9%$1.29B$390.29M22.9360

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:XRN) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel